Trial Profile
Real-world effectiveness and safety of Rivaroxaban and Warfarin in nonvalular atrial fibrillation patients with Heart failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 17 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology